HeartBeat.bio is a privately funded drug discovery company focusing on the development of a high-throughput 3D screening platform.
HeartBeat.bio has raised €6.0M across 2 funding rounds from 5 investors, most recently a Seed round in Nov 2023. Based in Vienna, Austria; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2023-11-02 | Seed | €4.5M | aws Gründungsfonds II,i&i Biotech Fund,Invest AG,Tensor Ventures | View deal → |
| 2021-05-04 | Seed | €1.5M | red-stars.com | View deal → |
